Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Prednisolone caproate is a synthetic corticosteroid ester, specifically the caproic acid (hexanoic acid) ester of prednisolone. It is classified as a glucocorticoid and is indicated for the treatment of hemorrhoids, anal fissures, and proctitis. Like other glucocorticoids, it exerts anti-inflammatory and immunosuppressive effects by mimicking endogenous cortisol activity. The drug acts primarily by binding to the glucocorticoid receptor, leading to altered gene expression that suppresses inflammatory mediators and immune responses[2]. Prednisolone derivatives are widely used in medicine for their ability to reduce inflammation in various tissues.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on prednisolone caproate.